Iboga Inspired N-Indolylethyl-Substituted Isoquinuclidines as a Bioactive Scaffold: Chemoenzymatic Synthesis and Characterization as GDNF Releasers and Antitrypanosoma Agents
Open Access
- 27 January 2022
- Vol. 27 (3), 829
- https://doi.org/10.3390/molecules27030829
Abstract
The first stage of the drug discovery process involves the identification of small compounds with biological activity. Iboga alkaloids are monoterpene indole alkaloids (MIAs) containing a fused isoquinuclidine-tetrahydroazepine ring. Both the natural products and the iboga-inspired synthetic analogs have shown a wide variety of biological activities. Herein, we describe the chemoenzymatic preparation of a small library of novel N-indolylethyl-substituted isoquinuclidines as iboga-inspired compounds, using toluene as a starting material and an imine Diels–Alder reaction as the key step in the synthesis. The new iboga series was investigated for its potential to promote the release of glial cell line-derived neurotrophic factor (GDNF) by C6 glioma cells, and to inhibit the growth of infective trypanosomes. GDNF is a neurotrophic factor widely recognized by its crucial role in development, survival, maintenance, and protection of dopaminergic neuronal circuitries affected in several neurological and psychiatric pathologies. Four compounds of the series showed promising activity as GDNF releasers, and a leading structure (compound 11) was identified for further studies. The same four compounds impaired the growth of bloodstream Trypanosoma brucei brucei (EC50 1–8 μM) and two of them (compounds 6 and 14) showed a good selectivity index.Funding Information
- Agencia Nacional de Investigación e Innovación (Fondo María Viñas FMV_1_2014_1_103488))
- Comisión Sectorial de Investigación Científica (CSIC-Grupos I+D 1063, PEDECIBA)
This publication has 34 references indexed in Scilit:
- New organoruthenium complexes with bioactive thiosemicarbazones as co-ligands: potential anti-trypanosomal agentsDalton Transactions, 2011
- Role of BDNF and GDNF in drug reward and relapse: A reviewNeuroscience & Biobehavioral Reviews, 2010
- Driving GDNF expression: The green and the red traffic lightsProgress in Neurobiology, 2008
- Effects of Amphotericin B on the expression of neurotoxic and neurotrophic factors in cultured microgliaNeurochemistry International, 2008
- GDNF family receptor complexes are emerging drug targetsTrends in Pharmacological Sciences, 2007
- Specific regulation of rat glial cell line‐derived neurotrophic factor gene expression by riluzole in C6 glioma cellsJournal of Neurochemistry, 2006
- Novel functions and signalling pathways for GDNFJournal of Cell Science, 2003
- In Vitro Activities of Iboga Alkaloid Congeners Coronaridine and 18-Methoxycoronaridine againstLeishmania amazonensisAntimicrobial Agents and Chemotherapy, 2002
- The GDNF family: Signalling, biological functions and therapeutic valueNature Reviews Neuroscience, 2002
- Isolation of Bis-Indole Alkaloids with Antileishmanial and Antibacterial Activities fromPerschiera van heurkii(Syn.Tabernaemontana van heurkii)Planta Medica, 1994